Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum93621Research ArticleNimesulid vo vtorom desyatiletii XXI vKarateevA. E-1502201214210411028122021Copyright © 2012, Consilium Medicum2012хроническая больнестероидные противовоспалительные препаратыНимесулид[Насонов Е.Л. Нестероидные противовоспалительные препараты (Перспективы применения в медицине). М.: Анко, 2000.][Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009.][Lee Y, Wolfe F, Michaud K. Patterns of Pain Medication Use Among Rheumatoid Arthritis Patients From 2000–2010. Arthritis Rheum 2011; 63 (10) (Suppl.): 159–60.][Zhu K, Devine A, Dick I, Prince R. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women. Spine 2007; 32 (18): 2012–8.][Nüesch E, Dieppe P, Reichenbach S et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011; 342: d1165. doi: 10.1136/bmj.d1165.][Tsuboi M, Hasegawa Y, Matsuyama Y et al. Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan? J Bone Miner Metab 2011; 29 (2): 217–23.][Milder T, Lipworth W, Williams K et al. «It looks after me»: How older patients make decisions about analgesics for osteoarthritis. Arthritis Care Res (Hoboken) 2011; 63 (9): 1280–6.][Lee T, Bartle B, Weiss K. Impact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veterans. Am J Med 2007; 120 (1): 98–104.][Goodson N, Brookhart A, Symmons D et al. Non - steroidal anti - inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 2009; 68 (3): 367–72.][Singh G. Recent consideration in nonsteroidal anti - inflammatory drug gastropathy. Am J Med 1998; 105: 31–8.][Lanas A. Prevention and treatment of NSAID-induced gastrointestinal injury. Curr Treat Options Gastroenterol 2006; 9: 147–56.][Каратеев А.Е., Насонова В.А. Развитие и рецидивирование язв желудка и двенадцатиперстной кишки у больных, принимающих нестероидные противовоспалительные препараты: влияние стандартных факторов риска. Тер. архив. 2008; 5: 62–6.][Hochman J, Shah N. What Price Pain Relief? Circulation 2006; 113: 2868–70.][Hermann M. Cardiovascular risk associated with nonsteroidal anti - inflammatory drugs. Curr Rheumatol Rep 2009; 11 (1): 31–5.][Fosbøl E, Folke F, Jacobsen S et al. Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals. Circ Cardiovasc Qual Outcomes 2010; 3: 395–405.][McGettigan P, Henry D. Cardiovascular risk with nonsteroidal anti - inflammatory drugs: systematic review of population - based controlled observational studies. PLoS Med 2011; DOI:10.1371/journal.pmed.1001098.][Aw T-J, Haas S, Liew D. Meta - analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med 2005; 165: 490–6.][Lanas A, Tornero J, Zamorano J. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis 2010; 69 (8): 1453–8.][Насонов Е.Л. Анальгетическая терапия в ревматологии: путешествие между Сциллой и Харибдой. Клин. фармакол. терапия. 2003; 12 (1): 64–9.][Барскова В.Г. Письмо редактора. Совр. ревматол. 2011; 2: 82–3.][Inotai A, Hankó B, Mészáros A. Trends in the non - steroidal anti - inflammatory drug market in six Central-Eastern European countries based on retail information. Pharmacoepidemiol Drug Saf 2010; 19 (2): 183–90.][Mattia C, Ciarcia S, Muhindo A, Coluzzi F. Nimesulide: 25 years later. Minerva Med 2010; 101 (4): 285–93.][Насонов Е.Л. Эффективность и переносимость нестероидного противовоспалительного препарата. Нимесулид: новые данные. РМЖ. 2001; 15: 6–8.][Rainsford K. Current status of the therapeutic uses and actions of the preferential cyclo - oxygenase-2 NSAID, nimesulide. Inflammopharmacology 2006; 14 (3–4): 120–37.][Bennett A. Nimesulide a well established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Therapeutic Roles of Selective COX-2 Inhibitors. Editors Vein J.R., Botting R.M. William Harvey Press: 524–540.][Binning A. Nimesulide in the treatment of postoperative pain: a double - blind, comparative study in patients undergoing arthroscopic knee surgery. Clin J Pain 2007; 23 (7): 565–70.][Wober W, Rahlfs V, Buchl N et al. Comparative efficacy and safety of the non - steroidal anti - inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int J Clin Pract 1998;52 (3): 169–75.][Pohjolainen T, Jekunen A, Autio L, Vuorela H. Treatment of acute low back pain with the COX-2-selective anti - inflammatory drug nimesulide: results of a randomized, double - blind comparative trial versus ibuprofen. Spine 2000; 25 (12): 1579–85.][Konstantinovic L, Kahjun Z, Milovanovic A et al. Acute low back pain with radiculopathy: a double – blind, randomized, placebo - controlled study. Photomed laser surg 2010; 28 (4): 555–60.][Lücker P, Pawlowski C, Friedrich I et al. Double - blind, randomised, multi - centre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodalac in patients suffering from osteoarthritis of the knee. Eur J Rheumatol Inflamm 1994; 14 (2): 29–38.][Huskisson E, Macciocchi A, Rahlfs V et al. Nimesulide versus diclofenac in the treatment of osteoarthritis of the hip or knee: an active controlled equivalence study. Curr Ther Res 1999; 60: 253–65.][Kriegel W, Korff K, Ehrlich J et al. Double - blind study comparing the long - term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract 2001; 55 (8): 510–14.][Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int J Clin Pract (Suppl.) 2004; 144: 27–32.][Conforti A, Leone R, Moretti U et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf 2001; 24: 1081–90.][Laporte J, Ibanez L, Vidal X et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety 2004; 27: 411–20.][Helin-Salmivaara A, Virtanen A, Veslainen R et al. NSAID use and the risk of hospitalisation for first myocardial infarction in the general population: a national case - control study from Finland. Eur Heart 2006; 27: 1657–63.][Каратеев А.Е. Российский опыт применения нимесулида: обзор клинических испытаний. Cons. Med. 2011; 13 (9): 89–95.][Каратеев А.Е., Алексеева Л.И., Братыгина Е.А., Аширова Т.Б. Оценка частоты развития побочных эффектов при длительном применении нимесулида в реальной клинической практике. РМЖ. 2009; 17 (21): 1466–72.][Каратеев А.Е., Насонова В.А. НПВП-ассоциированная гепатопатия: проблема нимесулида. Научн. практ. ревматол. 2004; 1: 34–7.][Каратеев А.Е., Барскова В.Г. Безопасность нимесулида: эмоции или взвешенная оценка? Cons. Med. 2007; 9: 60–4.][Rainsford K. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161–70.][Bennett A. Nimesulide a well established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Therapeutic Roles of Selective COX-2 Inhibitors. Editors Vein J.R., Botting R.M. William Harvey Press: 524–540.][HELSINN’s response. На сайте: HELSINN, 2002, 12. На сайте: http://www.pharmabiz.com.][Irish Board Suspends Marketing of Drugs Containing Nimesulide На сайте: http://www.imb.ie.][Press release. European Medicines Agency recommends restricted use of nimesulid - containing medicinal products. Doc Ref EMEA/432604/2007. На сайте: http://www.emea.europa.eu.][Press release. 23/06/2011 European Medicines Agency concludes review of systemic nimesulide - containing medicines. На сайте: http://www.ema.europa.eu/ema/][Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in patient treated with COX-2 selective inhibitors or nonselective NSAIDs: A case/noncase analysis of spontaneous reports. Clin Ther 2006; 28 (8): 1123–32.][Traversa G, Bianchi C, Da Cas R et al. Cohort study of hepatotoxity associated with nimesulide and other non - steroidal anti - inflammatory drugs. BMJ 2003; 327: 18–22.]